NDC 68788-8763-01 - Dexamethasone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8763
- Requested NDC
- 68788-8763-01
- Package NDCs from labels
- 68788-8763-1, 68788-8763-2, 68788-8763-3, 68788-8763-0, 68788-8763-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-01-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Tablets, USP | Preferred Pharmaceuticals Inc. | 2026-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8763-0 | Dexamethasone | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 68788-8763-1 | Dexamethasone | 12 in 1 BOTTLE | TABLET | 12 | 2 | |
| 68788-8763-2 | Dexamethasone | 21 in 1 BOTTLE | TABLET | 21 | 2 | |
| 68788-8763-3 | Dexamethasone | 30 in 1 BOTTLE | TABLET | 30 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8763 | DEXAMETHASONE TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 4 package rows | 20241113_64577454-d49e-4180-99e6-8461f74b0221.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8763-0 | EA - Each | 68788-8763 | 73b37d2c-7deb-428c-966c-e729ce80b518 | 1 | 2025-02-10 |
| 68788-8763-1 | EA - Each | 68788-8763 | 2cbcf06f-719b-4db2-87d1-69b48817d904 | 1 | 2025-02-10 |
| 68788-8763-2 | EA - Each | 68788-8763 | bd7d0917-7dfc-4946-9fe8-091d2e72eb00 | 1 | 2025-02-10 |
| 68788-8763-3 | EA - Each | 68788-8763 | 4e9107e1-bc1f-41cb-b0d3-9f5bef02d973 | 1 | 2025-02-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone | DEXAMETHASONE | Bionpharma Inc., | 3166db4f-66a5-496a-a194-3cc01b7347d3 | 2025-03-05 | Warnings, Adverse reactions | 197582 197583 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | NuCare Pharmaceuticals, Inc. | 2f780550-ecbf-98fc-e063-6294a90a11c0 | 2025-03-03 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Alcostat | TARAXACUM OFFICINALE, AVENA SATIVA, PASSIFLORA INCARNATA, AURUM METALLICUM, CAPSICUM ANNUUM, CHELIDONIUM MAJUS, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NOX VOMICA, QUERCUS GLANDIUM SPIRITUS, SULPHURICUM ACIDUM, ETHYLICUM, CARCINOSIN, SACCHARUM OFFICINALE | Energique, Inc. | 77daea02-3c32-4ba3-a7a8-af79b13ddc06 | 2025-02-27 | Warnings | C151H8M554 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc. | cf1a6da8-ba79-4bff-a13b-6effb67f6c1c | 2025-02-20 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | b883860c-27ba-4bac-8ae3-4cf4d82d5071 | 2025-02-10 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | b7b39ad5-e158-b8fe-e053-2995a90a5279 | 2025-02-07 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Prasco Laboratories | bfce6b49-f7ff-4ec7-9580-b730f0a207d7 | 2025-02-01 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Sandoz Inc | 89fef4d2-7078-47f1-96bf-aca50b135a97 | 2025-01-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Redpharm Drug, Inc. | 115e1bfb-1697-d567-e063-6394a90a78e5 | 2025-01-23 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | e90cb7f5-5e99-fbf3-e053-2995a90a70aa | 2025-01-22 | Warnings, Adverse reactions | 343033 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | fade983c-81fb-df94-e053-6394a90a7560 | 2025-01-22 | Warnings, Adverse reactions | 197580 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | 044d7898-4ab6-a0b3-e063-6294a90acdba | 2025-01-22 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Anise Pyrite | ANISE PYRITE | Uriel Pharmacy Inc. | a03cdeb0-8347-40cc-8d17-5510d99575c7 | 2025-01-22 | Warnings | C151H8M554 |
| DEXAMETHASONE | DEXAMETHASONE | Direct Rx | cc7140de-a205-f675-e053-2995a90ac22b | 2025-01-20 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Tobradex ST | TOBRAMYCIN / DEXAMETHASONE | Eyevance Pharmaceuticals, LLC | c2d7325e-4f58-5590-e053-2a95a90ace1b | 2025-01-16 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | 955db121-79f4-47eb-8c10-01b2d8b411e4 | 2025-01-13 | Warnings, Adverse reactions | 343033 7S5I7G3JQL |
| A-5 | SUCROSE | DNA Labs, Inc. | 8e63f697-26c1-4518-acd3-5ea72cfa27f7 | 2025-01-09 | Warnings | C151H8M554 |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Advanced Rx of Tennessee, LLC | 09315f0b-f15a-30d5-e063-6394a90ac8dd | 2024-12-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | Advanced Rx Pharmacy of Tennessee, LLC | f1a05d5f-74f2-17a1-e053-2995a90ab0e7 | 2024-12-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Tobramycin and dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | Advanced Rx Pharmacy of Tennessee, LLC | f4c00d9c-3a17-06a0-e053-2a95a90a8413 | 2024-12-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.